Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026)
Cytosorbents' (CTSO) quarterly Exchange Rate Effect came in at -$228000.0 in Q1 2026, down 914.29% YoY from $28000.0 in Q1 2025, and down 116.88% on a QoQ basis from $1.4 million in Q4 2025.
Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 14 years of Exchange Rate Effect data on file, last reported at -$228000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 914.29% year-over-year to -$228000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2065.53% YoY) and the FY2025 annual result came in at $1.5 million, up 1852.94% from the prior year.
- Exchange Rate Effect eased to -$228000.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.4 million in Q4 2025 to a low of -$228000.0 in Q1 2026.
- A 5-year average of $47900.4 and a median of -$35003.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 3150.12% — and 2025, when it jumped 1374.53%.
- Tracing CTSO's Exchange Rate Effect over 5 years: stood at $138734.0 in 2022, then plunged by 171.05% to -$98564.0 in 2023, then fell by 7.54% to -$106000.0 in 2024, then jumped by 1374.53% to $1.4 million in 2025, then slumped by 116.88% to -$228000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$228000.0 (Q1 2026), $1.4 million (Q4 2025), and -$146000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -14.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.80 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -4.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 38.36 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -2.30 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176,000.00 |
| Jun 30, 2026 | 176,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -146,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | -69,782.00 |
| Jun 30, 2024 | -69,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Mar 31, 2024 | 5,782.00 |